Strata Skin Sciences (SSKN)

• Market cap: $10.6M
• 1 day: 0.40%
• 5 days: -2.69%
• 1 month: -3.80%
• 3 months: -13.06%
• 6 months: -14.53%
• Year to date: -17.32%
• 1 year: -51.63%
• 5 years: -71.89%
• 10 years: -96.84%
• Sector: Healthcare
• Industry: Medical Devices

About: Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Employees: 106

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

6% more capital invested

Capital invested by funds: $3.32M [Q3] → $3.51M (+$188K) [Q4]

0% more ownership

Funds ownership: 28.95% [Q3] → 28.95% (+0%) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

16% less funds holding

Funds holding: 19 [Q3] → 16 (-3) [Q4]

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $6 137% upside
• Avg. target: $6 137% upside
• High target: $6 137% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Anthony Vendetti 33% 1-year accuracy 6 / 18 met price target

137% upside $6

Buy Initiated

27 Feb 2025